The content is available as a PDF (319.6 KB).
letter . 2020 Apr 21:dgaa224. doi: 10.1210/clinem/dgaa224
Letter to the Editor: “Our Response to COVID-19 as Endocrinologists and Diabetologists”
Leandro Kasuki
1,2,3, Mônica R Gadelha
1,2,4,✉
Leandro Kasuki
1
Neuroendocrinology Research Center/ Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
2
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
3
Endocrinology Division – Hospital Federal de Bonsucesso, Rio de Janeiro Brazil
Find articles by Leandro Kasuki
Mônica R Gadelha
1
Neuroendocrinology Research Center/ Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
2
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
4
Neuropatology and Molecular Genetics Laboratory – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Find articles by Mônica R Gadelha
1
Neuroendocrinology Research Center/ Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
2
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
3
Endocrinology Division – Hospital Federal de Bonsucesso, Rio de Janeiro Brazil
4
Neuropatology and Molecular Genetics Laboratory – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
✉
Corresponding email: mgadelha@hucff.ufrj.br
Received 2020 Apr 15.
Keywords: acromegaly, coronavirus, COVID-19, SARS-CoV-2, somatostatin receptor ligands
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7188172 PMID: 32315031
See "Our Response to COVID-19 as Endocrinologists and Diabetologists" in volume 105 on page 1299.